David Wald, MD, PhD
Professor, Department of Pathology
Co-Leader, Immune Oncology Program
Associate Director, MSTP Program
Case Comprehensive Cancer Center
Case Western Reserve University
Cleveland, Ohio, United States
The Telegraft is proud to feature Dr. David Wald, MD, Ph.D., a physician-scientist at Case Western Reserve University. Dr. Wald is a Professor in the Department of Pathology, Co-Leader of the Immune Oncology Program at Case Comprehensive Cancer Center, and Associate Director of the MSTP Program at the School of Medicine. Notably, Dr. Wald received the Top Abstract Award at this year’s ISCT Annual Meeting in New Orleans for his abstract entitled, “Development and Clinical Validation of a Less Than 1 Day CAR-T Manufacturing Process.” (1) This platform represents a potential breakthrough in making CAR-T cell therapy faster, safer, and more accessible. Dr. Wald discussed more about this work with Telegraft editor, Dr. Ashley Krull, Ph.D. Listen in to hear more about Dr. Wald’s experience as a first-time ISCT meeting attendee, the strategy behind the creation of the Ultra Fast CAR T production platform, and the outlook for this technology to increase patient safety and access to this life-saving therapeutic.
References
1. https://www.sciencedirect.com/science/article/pii/S1465324925001021
#CommunityFeature
#News
#Blogs